Spatial Genomics

Spatial Genomics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $15.5M

Overview

Spatial Genomics is a private, early-stage biotech company commercializing a proprietary spatial multi-omics platform called GenePS. Its core technology, seqFISH, combines high-resolution imaging with combinatorial molecular barcoding to map hundreds to tens of thousands of biomolecules within single cells in their native tissue context, offering superior multiplexing and single-molecule sensitivity. The company is positioned to serve the rapidly growing research tools market, targeting academic, biopharma, and diagnostic researchers seeking to understand complex biology in health and disease.

Genetics & GenomicsProteomics

Technology Platform

Sequential Fluorescence In Situ Hybridization (seqFISH) combined with high-resolution confocal imaging and advanced fluidics for highly multiplexed, spatial multi-omic analysis of RNA, DNA, and protein within intact cells and tissues.

Funding History

2
Total raised:$15.5M
Series A$12M
Seed$3.5M

Opportunities

The rapidly expanding spatial biology market, driven by demand from academic and biopharma researchers, presents a major growth opportunity.
The platform's unique ability to perform high-plex, multi-omic analysis in situ could position it as a preferred tool for understanding complex diseases and developing targeted therapies.

Risk Factors

Key risks include intense competition from established spatial genomics companies, the technical and commercial challenge of driving adoption of a complex new workflow, and the financial pressures typical of an early-stage, capital-intensive hardware/consumables business.

Competitive Landscape

Spatial Genomics competes in the crowded spatial genomics market against companies like 10x Genomics (Visium), NanoString (GeoMx), Akoya Biosciences, and newer entrants like Vizgen and Resolve Biosciences. It differentiates primarily through its seqFISH technology, which offers potentially higher multiplexing and integrated DNA/protein detection from a single platform.